Wednesday, April 24, 2024
4/24/2024
ABSTRACT The GWAS community has now identified many thousands of variants that affect complex traits, but there is still a critical gap in our ability to interpret why these variants matter. While some signals affect genes that are directly involved in the relevant disease processes, many other signals likely arise due to indirect trans- regulatory effects on core disease genes and pathways. There has been huge progress in recent years on methods to identify variants that affect cis-regulation of nearby genes, but it remains extremely difficult to measure and interpret how and whether those associated genes may affect disease processes directly or via trans-acting effects on other genes. In this grant we propose to develop new experimental and computational methods to help bridge this critical gap. We have recently developed two complementary experimental techniques that use CRISPR-perturbations to map out the upstream regulators and downstream targets of a gene of interest. We will work on methodological improvements for these methods, and apply them in effector T cells and regulatory T cells to map out gene regulatory networks in these important immune cell types. We will develop new computational methods for inferring gene networks using these data. Finally, we will develop and implement new methods for interpreting autoimmune disease loci in light of the network information. This project will establish new high throughput techniques for elucidating regulatory relationships among genes and for using these to interpret GWAS data.
HHS’ Tracking Accountability in Government Grants System (TAGGS) website provides access to detailed descriptions of grants, loans, aggregated direct payments and other types of financial assistance awarded by the HHS Operating Divisions (OPDIVs) and the Office of the Secretary Staff Divisions (STAFFDIVs).
